These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31587697)

  • 1. One year in review 2019: systemic sclerosis.
    Barsotti S; Orlandi M; Codullo V; Di Battista M; Lepri G; Della Rossa A; Guiducci S
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):3-14. PubMed ID: 31587697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macro- and microvascular disease in systemic sclerosis.
    Kavian N; Batteux F
    Vascul Pharmacol; 2015 Aug; 71():16-23. PubMed ID: 26044180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year in review 2020: systemic sclerosis.
    Orlandi M; Lepri G; Damiani A; Barsotti S; Di Battista M; Codullo V; Della Rossa A; Guiducci S; Allanore Y
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):3-17. PubMed ID: 32662404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis.
    Manetti M; Milia AF; Guiducci S; Romano E; Matucci-Cerinic M; Ibba-Manneschi L
    J Rheumatol; 2011 Feb; 38(2):297-301. PubMed ID: 21078716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.
    Allanore Y; Meune C
    Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S48-53. PubMed ID: 21050545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting interferons as a strategy for systemic sclerosis treatment.
    Ciechomska M; Skalska U
    Immunol Lett; 2018 Mar; 195():45-54. PubMed ID: 29106987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiologic aspects of systemic sclerosis].
    Gran JT; Molberg Ø; Midtvedt Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2622-3. PubMed ID: 16215604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of systemic sclerosis.
    Artlett CM
    Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
    Radić M; Kaliterna DM; Fabijanić D; Radić J
    Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of systemic sclerosis: an update.
    Romano E; Manetti M; Guiducci S; Ceccarelli C; Allanore Y; Matucci-Cerinic M
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S75-86. PubMed ID: 21586222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-related differences in systemic sclerosis.
    Hughes M; Pauling JD; Armstrong-James L; Denton CP; Galdas P; Flurey C
    Autoimmun Rev; 2020 Apr; 19(4):102494. PubMed ID: 32062031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparing effect of hemiplegia on skin fibrosis and microvascular involvement: reports of two cases of systemic sclerosis and review of the literature.
    Ughi N; Hervey SA; Gualtierotti R; Silvana Z; Herrick AL; Ingegnoli F; Meroni P
    Semin Arthritis Rheum; 2015 Apr; 44(5):597-601. PubMed ID: 25488380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat patients with systemic sclerosis in clinical practice.
    Rossi D; Zanatta E; Marson P; Sciascia S; Polito P; Roccatello D; Cozzi F
    Autoimmun Rev; 2017 Oct; 16(10):1024-1028. PubMed ID: 28778710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis refractory disease: from the skin to the heart.
    Almeida I; Faria R; Vita P; Vasconcelos C
    Autoimmun Rev; 2011 Sep; 10(11):693-701. PubMed ID: 21575745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current treatment of systemic scleroderma].
    Hunzelmann N
    Hautarzt; 2018 Nov; 69(11):901-907. PubMed ID: 30143809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis: one year in review 2022.
    Lepri G; Orlandi M; Di Battista M; De Mattia G; Da Rio M; Codullo V; Guiducci S; Della Rossa A
    Clin Exp Rheumatol; 2022 Oct; 40(10):1911-1920. PubMed ID: 36135958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pathogenic and therapeutic concepts in systemic sclerosis.
    Hügle T; Huigens CA; van Laar JM
    Arzneimittelforschung; 2009; 59(12):615-24. PubMed ID: 20108646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
    Antic M; Distler JH; Distler O
    Curr Opin Pharmacol; 2013 Jun; 13(3):455-62. PubMed ID: 23747024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
    Yanaba K
    J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.